|
|
|
News
|
Gamida Cell Ltd.
|
|
10-02-2010
|
|
Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma.
StemEx study is enrolling patients at cord blood transplant centers in the U.S., Spain, Italy, Hungary and Israel.
|
|
|
Gamida Cell Ltd.
|
|
18-01-2010
|
|
European Medicines Agency (EMA) Waives Requirement to Test StemEx® in Paediatric Patients 17 Years of Age and Under
|
|
|
D-Pharm Ltd.
|
|
31-12-2009
|
|
D-Pharm (DPRM: TASE) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
|
|
|
Optonol Ltd.
|
|
14-12-2009
|
|
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
|
|
|
Gamida Cell Ltd.
|
|
02-12-2009
|
|
Gamida Cell Announces Feasibility Study with Weill Cornell Medical College
Study is testing a new method to deliver gene correction cells to treat congenital conditions such as Cooley's Anemia
|
|
|
D-Pharm Ltd.
|
|
09-11-2009
|
|
D-Pharm Enters into Collaboration with Wanbang Biopharmaceuticals to Increase the Potential Market for its Stroke Drug-Candidate DP-b99.
|
|
|
Gamida Cell Ltd.
|
|
02-11-2009
|
|
StemEx® Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cord Blood Symposium in Israel. StemEx is currently being studied in the international ExCell Phase II/III trial as a treatment for leukemia and lymphoma
|
|
|
Gamida Cell Ltd.
|
|
21-10-2009
|
|
Gamida Cell and Cellerix Partner on Feasibility Study
Pre-clinical study will test new method of improving clinical efficacy ofexpanded populations of adult stem cells obtained from adipose tissue
|
|
|
OrSense Ltd.
|
|
19-10-2009
|
|
OrSense`s NBM-200MP System for Continuous Non-Invasive Hemoglobin and Blood Oximetry Measurements Achieves Superior Performance in Hospital Setting
|
|
|
Home Skinovations Ltd.
|
|
08-10-2009
|
|
Silk'n SensEpil TM Launches at Saks Fifth Avenue Stores Around the US
|
|
|
|
|